Chief Pharmacist

Computer System Assurance

Chief Pharmacist

Computer System Assurance (CSA) refers to the comprehensive and systematic approach taken by organizations to ensure the reliability, security, and ...

CSV Qualification Summary Report

Chief Pharmacist

A Computer System Validation (CSV) Qualification Summary Report is a comprehensive document that provides an overview of the validation process ...

Difference Between 21 CFR Part 11 and Annex 11

Chief Pharmacist

21 CFR Part 11 and Annex 11 are both regulatory guidelines that provide requirements for electronic records and electronic signatures ...

What is a Non-GxP System?

Chief Pharmacist

Non-GxP systems do not affect product quality, patient safety, or regulatory decisions. Validation effort here is minimal or not required. ...

Determining GxP Relevant Software

Chief Pharmacist

Determining whether a software system is GxP (Good Practice) relevant in the pharmaceutical industry involves assessing its impact on processes ...

Software Development Life Cycle in Pharmaceutical Industry

Chief Pharmacist

In the pharmaceutical industry, the software development life cycle (SDLC) consists of several phases that ensure the proper development, validation, ...

URS | The Foundation of CSV

Chief Pharmacist

The User Requirements Specification (URS) defines what the user expects from the system from a business and compliance perspective, without ...

Is Coning Always a Problem?

Chief Pharmacist

One of the most common myths analysts come to me with is that coning is always a problem to be ...

New Biosimilar Era | FDA’s Biggest Shift

Chief Pharmacist

FDA has delivered the most consequential policy change in two decades, a shift that fundamentally transforms how our industry will ...

Common Technical Document (CTD)

Chief Pharmacist

The Common Technical Document (CTD) is one of the most significant harmonisation achievements in global regulatory science. Before CTD, every ...

Inspection Readiness | From Audit Week to Always-On

Chief Pharmacist

I have lost count of how many times I have seen teams go into panic mode the week before an ...

Understanding D50 in Particle Size Distribution of API – Why It Matters!

Chief Pharmacist

In pharmaceutical development, Particle Size Distribution (PSD) is a critical quality attribute—especially for Active Pharmaceutical Ingredients (APIs). Among the PSD ...

12314 Next